Full Press Release Details
| Corporate Relationship Department | National Stock Exchange of India Ltd. |
| BSE Limited | "Exchange Plaza" |
| Dalal Street, Fort | Bandra-Kurla Complex, Bandra (East), |
| Mumbai - 400 001 | Mumbai - 400 051 |
| Fax Nos.: 022-22723121 / 22723719 / | Fax Nos.: 022-26598120/ 26598237/ |
| 22722037 / 22722039 | 26598238 |
| Scrip Code: 500124 | Scrip Code: DRREDDY-EQ |
Further to our intimations dated August 20, 2019 and February 16, 2020 with regard to the audit of our Formulations Manufacturing Plant ("Vizag SEZ Plant 1 - FTO 7") at Duvvada, Visakhapatnam, we would like to inform you that we have received the Establishment Inspection Report (EIR) from US FDA, for the above-referred facility, indicating closure of the audit. As intimated earlier the facility has been classified as VAI (Voluntary Action Indicated)
This is for your information.
| /s/ Vikas Sabharwal | |
| Vikas Sabharwal | |
| Assistant Company Secretary |
CC:- New York Stock Exchange Inc.(Stock Code :RDY)